Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Liver Diseases

  Free Subscription


Articles published in J Hepatol

Retrieve available abstracts of 399 articles:
HTML format
Text format



Single Articles


    January 2012
  1. GALMOZZI E , Colombo M
    Genetic testing for hepatocellular carcinoma: an ambitious goal still to achieve.
    J Hepatol. 2012.
    PubMed     Text format     Related articles   



  2. FARINATI F , Giacomin A, Vanin V, Giannini E, et al
    TACE treatment in hepatocellular carcinoma: what should we do now?
    J Hepatol. 2012.
    PubMed     Text format     Related articles   



  3. VILLANUEVA A , Forns X, Llovet JM
    Molecular epidemiology in HCV-related hepatocellular carcinoma: first steps.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  4. ANTOINE DJ , Jenkins RE, Dear JW, Williams DP, et al
    Molecular forms of HMGB1 and Keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  5. SHAH N , Dhar D, Mohammed F, Habtesion A, et al
    Prevention of Acute Kidney Injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  6. MEMON K , Kulik L, Lewandowski RJ, Wang E, et al
    Alpha-fetoprotein Response Correlates with EASL Response and Survival in Solitary Hepatocellular Carcinoma Treated with Trans-arterial Therapies: A Subgroup Analysis.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  7. BOONSTRA K , Beuers U, Ponsioen CY
    Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  8. PEREIRA G , Guevara M, Fagundes C, Sola E, et al
    Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  9. HAYASHI H , Mizuno T, Horikawa R, Nagasaka H, et al
    4-phenylbutyrate modulates ubiquitination of hepatocanalicular MRP2 and reduces serum total bilirubin concentration.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  10. CUCCHETTI A , Trevisani F, Cescon M, Ercolani G, et al
    Cost-effectiveness of semiannual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  11. STRAZZABOSCO M , Fabris L
    Development Of The Bile Ducts: Essentials For The Clinical Hepatologist.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  12. PISCHKE S , Gosling J, Engelmann I, Schlue J, et al
    High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  13. RAOUL JL , Bruix J, Greten TF, Sherman M, et al
    Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  14. SHIMODA M , Tomimaru Y, Charpentier KP, Safran H, et al
    Tumor progression-related transmembrane protein aspartate beta-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  15. HSU C , Yang TS, Huo TI, Hsieh RK, et al
    Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  16. SHAWCROSS DL , Austin MJ, Abeles RD, McPhail MJ, et al
    The Impact of Organ Dysfunction in Cirrhosis: Survival at a Cost?
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  17. RODRIGUEZ-VILARRUPLA A , Lavina B, Garcia-Caldero H, Russo L, et al
    PPARalpha Activation Improves Endothelial Dysfunction And Reduces Fibrosis And Portal Pressure In Cirrhotic Rats.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  18. GUOHONG C , Ya L, Wen Y
    Deregulation of microRNAs expression occurs in stages of multistep hepatocarcinogenesis: why is it different?
    J Hepatol. 2012.
    PubMed     Text format     Related articles   



  19. MERLI M , Lucidi C
    Bacterial resistance in cirrhotic patients: an Emerging reality.
    J Hepatol. 2012.
    PubMed     Text format     Related articles   



  20. WONG CM , Ng IO
    Reply to: "Deregulation of microRNAs expression occurs in stages of multistep hepatocarcinogenesis: why is it different?"
    J Hepatol. 2012.
    PubMed     Text format     Related articles   



  21. SAMUEL D
    The Journal of Hepatology: An international journal in a new era.
    J Hepatol. 2012;56:4.
    PubMed     Text format     Related articles   



    December 2011
  22. WILSON GK , Brimacombe CL, Rowe IA, Reynolds GM, et al
    A dual role for hypoxia inducible factor-1alpha in the hepatitis C virus lifecycle and hepatoma migration.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  23. BECHMANN LP , Hannivoort RA, Gerken G, Hotamisligil GS, et al
    The Interaction of Hepatic Lipid and Glucose Metabolism in Liver Diseases.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  24. LEDINGHEN VD , Wong VW, Vergniol J, Wong GL, et al
    Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan(R)
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  25. SALMON D , Bani-Sadr F, Loko MA, Stitou H, et al
    Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-coinfected patients: Results from ANRS CO13 HEPAVIH.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  26. FEDE G , D'Amico G, Arvaniti V, Tsochatzis E, et al
    Renal failure and cirrhosis: a systematic review of mortality and prognosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  27. TAKAYASU K , Arii S, Kudo M, Ichida T, et al
    Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  28. TEUFEL A , Marquardt JU, Staib F, Galle PR, et al
    Snapshot liver transcriptome in Hepatocellular Carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  29. ALSINET C , Villanueva A, Llovet JM
    Cell population genetics and deep sequencing: a novel approach for drivers discovery in hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  30. NISCHALKE HD , Berger C, Luda C, Muller T, et al
    The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian Patients.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  31. TRITTO G , Mookerjee RP, Jalan R
    Reply to: The quest for the elusive factors that underpin neutrophil dysfunction in cirrhosis goes on.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  32. VIJAY GK , Taylor NJ, Shawcross DL
    The quest for the elusive factors that underpin neutrophil dysfunction in cirrhosis goes on.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



    October 2011
  33. STRATTON SA , Barton MC
    p53-mediated regulation of hepatic lipid metabolism: forging links between metabolism, atherogenesis and cancer.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  34. MONSENEGO J , Mansouri A, Akkaoui M, Lenoir V, et al
    Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  35. PIHLAJAMAKI J , Kuulasmaa T, Kaminska D, Simonen M, et al
    Serum Interleukin 1 Receptor Antagonist as an Independent Marker of Nonalcoholic Steatohepatitis in Humans.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  36. GUIU B , Deschamps F, Aho S, Munck F, et al
    Liver/Biliary Injuries following Chemoembolisation of Endocrine Tumours and Hepatocellular Carcinoma: Lipiodol Versus Drug-eluting Beads.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  37. KADRY Z , Schaefer EW, Uemura T, Shah AR, et al
    Impact of geographic disparity on liver allocation for hepatocellular cancer in the United States.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  38. CARDENAS A , Gines P, Marotta P, Czerwiec F, et al
    Tolvaptan, an Oral Vasopressin Antagonist, in the Treatment of Hyponatremia in Cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  39. URDZIK J , Bjerner T, Wanders A, Weis J, et al
    The value of pre-operative magnetic resonance spectroscopy in the assessment of steatohepatitis in patients with colorectal liver metastasis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  40. KUROSAKI M , Hiramatsu N, Sakamoto M, Suzuki Y, et al
    Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  41. HUYNH H , Chow PK, Tai WM, Choo SP, et al
    Dovitinib demonstrates anti-tumor and anti-metastatic activities in xenograft models of hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  42. LLEO A , Eric Gershwin M, Mantovani A, Invernizzi P, et al
    Towards Common Denominators in Primary Biliary Cirrhosis: The Role of IL-12.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  43. ASGHAR U , Meyer T
    Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  44. VON ARENSTORFF VILSTRUP H , Rehfeld JF
    Niels Tygstrup (27 May, 1926-20 February, 2009).
    J Hepatol. 2011;55:739-40.
    PubMed     Text format     Related articles   



  45. LISMAN T , Porte RJ
    Recombinant factor VIIa to treat severe bleeding in patients with liver disease: pitfalls and possibilities.
    J Hepatol. 2011;55:950-1.
    PubMed     Text format     Related articles   



  46. DONGIOVANNI P , Fracanzani AL, Fargion S, Valenti L, et al
    Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
    J Hepatol. 2011;55:920-32.
    PubMed     Text format     Related articles    Abstract available



  47. KOHLI R , Feldstein AE
    NASH animal models: are we there yet?
    J Hepatol. 2011;55:941-3.
    PubMed     Text format     Related articles   



  48. SHOUVAL D
    Focus.
    J Hepatol. 2011;55:741-2.
    PubMed     Text format     Related articles   



  49. FERENCI P
    Polymorphism of methylenetetrahydrofolate reductase as disease modifier - a deja-vu in Wilson disease?
    J Hepatol. 2011;55:753-5.
    PubMed     Text format     Related articles   



  50. JONES DE
    A potential retroviral aetiology for mouse PBC: more answers or more questions?
    J Hepatol. 2011;55:750-2.
    PubMed     Text format     Related articles   



  51. ZHANG G , Chen M, Graham D, Subsin B, et al
    Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models.
    J Hepatol. 2011;55:876-84.
    PubMed     Text format     Related articles    Abstract available



  52. GROMADZKA G , Rudnicka M, Chabik G, Przybylkowski A, et al
    Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson's disease.
    J Hepatol. 2011;55:913-9.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  53. ROBERTS LR , Garcia JA
    Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  54. HOSHIDA Y , Fuchs BC, Tanabe KK
    Genomic risk of hepatitis C-related hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  55. ALISON MR , Marongiu F, Laconi E
    Transplanted hepatocytes: wiped out or washed out?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  56. GAENS KH , Niessen PM, Rensen SS, Buurman WA, et al
    Endogenous formation of N(epsilon)-(Carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  57. NAHON P , Sutton A, Rufat P, Charnaux N, et al
    A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  58. FRIEDMAN SL
    Focus.
    J Hepatol. 2011;55:503-4.
    PubMed     Text format     Related articles   



  59. HUBSCHER SG
    What is the long-term outcome of the liver allograft?
    J Hepatol. 2011;55:702-17.
    PubMed     Text format     Related articles    Abstract available



  60. GARCIA-CORTES M , Stephens C, Lucena MI, Fernandez-Castaner A, et al
    Causality assessment methods in drug induced liver injury: strengths and weaknesses.
    J Hepatol. 2011;55:683-91.
    PubMed     Text format     Related articles    Abstract available



  61. YOUSUF F , Yeoman AD
    Do fatigue and UDCA therapy truly have independent effects on mortality in PBC?
    J Hepatol. 2011;55:729.
    PubMed     Text format     Related articles   



  62. LIU Y , Wang Z, Kwong SQ, Lui EL, et al
    Inhibition of PDGF, TGF-beta, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib.
    J Hepatol. 2011;55:612-25.
    PubMed     Text format     Related articles    Abstract available



  63. ZIMMERMANN E , Anty R, Tordjman J, Verrijken A, et al
    C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.
    J Hepatol. 2011;55:660-5.
    PubMed     Text format     Related articles    Abstract available



  64. ANDRADE V , Guerra M, Jardim C, Melo F, et al
    Nucleoplasmic calcium regulates cell proliferation through legumain.
    J Hepatol. 2011;55:626-35.
    PubMed     Text format     Related articles    Abstract available



  65. TANDRA S , Yeh MM, Brunt EM, Vuppalanchi R, et al
    Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.
    J Hepatol. 2011;55:654-9.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  66. BJORNSSON E , Jacobsen EI, Kalaitzakis E
    Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  67. LIU S , Guo W, Shi J, Li N, et al
    MicroRNA-135a Contributes to the Development of Portal Vein Tumor Thrombus by Promoting Metastasis in Hepatocellular Carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  68. LI Z , Huang X, Zhan H, Zeng Z, et al
    Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  69. KELLEY RK , Yao F
    Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation - A New Strategy?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  70. HSU CC , Schwabe RF
    Autophagy and hepatic stellate cell activation - partners in crime?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  71. LEVESQUE E , Hoti E, Azoulay D, Ichai P, et al
    Prospective Evaluation of the Prognostic Scores for Cirrhotic Patients admitted to an Intensive Care Unit.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  72. LLOP E , Berzigotti A, Reig M, Erice E, et al
    Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumours.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  73. SONG Y , Shan S, Zhang Y, Liu W, et al
    Ligand-Dependent Corepressor Acts as a Novel Corepressor of Thyroid Hormone Receptor and Represses Hepatic Lipogenesis in Mice.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  74. CHEN T , Chen Q, Xu Y, Zhou Q, et al
    SRC-3 is required for CAR-regulated hepatocyte proliferation and drug metabolism.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  75. SANGRO B , Inarrairaegui M, Bilbao JI
    Radioembolization for hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  76. SCHIRMACHER P , Bedossa P, Roskams T, Tiniakos DG, et al
    Fighting the bushfire in HCC trials.
    J Hepatol. 2011;55:276-7.
    PubMed     Text format     Related articles   



  77. PINZANI M
    Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?
    J Hepatol. 2011;55:459-65.
    PubMed     Text format     Related articles    Abstract available



  78. DOGRU T , Genc H, Ercin CN, Tapan S, et al
    Non-invasive prediction of fibrosis in non-alcoholic fatty liver disease.
    J Hepatol. 2011;55:498-9.
    PubMed     Text format     Related articles   



  79. GEIER A
    Shedding new light on vitamin D and fatty liver disease.
    J Hepatol. 2011;55:273-5.
    PubMed     Text format     Related articles   



  80. NAKANO T , Cheng YF, Lai CY, Hsu LW, et al
    Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats.
    J Hepatol. 2011;55:415-25.
    PubMed     Text format     Related articles    Abstract available



  81. KRAWCZYK M , Grunhage F, Zimmer V, Lammert F, et al
    Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease.
    J Hepatol. 2011;55:299-306.
    PubMed     Text format     Related articles    Abstract available



  82. PATSENKER E , Schneider V, Ledermann M, Saegesser H, et al
    Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
    J Hepatol. 2011;55:388-98.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  83. SHOUVAL D
    Embolization of hepatocellular carcinoma with drug-eluting beads: New insight into the biologic effects of tumor ablation.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  84. THOEN LF , Guimaraes EL, Dolle L, Mannaerts I, et al
    A role for autophagy during hepatic stellate cell activation.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  85. GIRES O
    Commentary on: Epithelial Cell Adhesion Molecule (EpCAM) Marks Hepatocytes Newly Derived from Stem/Progenitor Cells in Humans. Yoon et al.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  86. SCHLOSSER B , Stein A, Neuhaus R, Pahl S, et al
    Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  87. SMITH FE , Mardini H, Record CO, Blamire AM, et al
    Reply to: Ammonia and Cerebral Water. Importance of Structural Analysis Of The Brain in Hepatic Encephalopathy.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  88. AGHEMO A , Colombo M
    Peginterferon Maintenance Therapy in Patients with Advanced Hepatitis C to Prevent Hepatocellular Carcinoma: The Plot Thickens.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  89. SHIM JH , Lee HC, Won HJ, Shin YM, et al
    Maximum Number of Target Lesions Required to Measure Responses to Transarterial Chemoembolization Using the Enhancement Criteria in Patients with Intrahepatic Hepatocellular Carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  90. APPELHANS K , Frankos V
    Herbal Medicine Hepatotoxicity Revisited.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  91. MALLAT A , Lotersztajn S
    The liver x receptor in hepatic stellate cells: a novel antifibrogenic target ?
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  92. MARQUARDT JU , Galle PR, Teufel A
    Molecular diagnosis and therapy of hepatocellular carcinoma (HCC); An emerging field for advanced technologies.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  93. CASTERA L , Pinzani M, Bosch J
    Non Invasive Evaluation of Portal Hypertension Using Transient Elastography.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  94. LARREY D , Faure S
    Reply to the letter to the editor "Herbal Medicine Hepatotoxicity Revisited"
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  95. IKEJIMA K , Ishikawa S, Watanabe S
    Potential differences in subpopulations of hepatic NKT cells in xenobiotics-induced liver injury and fibrogenesis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  96. LINDER S
    Caspase-cleaved keratin 18 as a biomarker for non-alcoholic steatohepatitis (NASH) - the need for correct terminology.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  97. MCPHAIL MJ , Dhanjal NS, Grover VP, Taylor-Robinson SD, et al
    Ammonia and Cerebral Water. Importance of Structural Analysis Of The Brain in Hepatic Encephalopathy.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  98. MEDERACKE I , Filmann N, Yurdaydin C, Bremer B, et al
    Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis Delta antigen persistence after liver transplantation.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  99. WANG JH , Wang CC, Hung CH, Chen CL, et al
    Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  100. SELZNER N , Liu H, Boehnert MU, Adeyi OA, et al
    FGL2/Fibroleukin Mediates Hepatic Reperfusion Injury by Induction of Sinusoidal Endothelial Cell and Hepatocyte Apoptosis in Mice.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  101. G FB , J MM, U LM, I U, et al
    Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  102. SHI Y , Rehman H, Ramshesh VK, Schuartz J, et al
    Sphingosine Kinase-2 Inhibition Improves Mitochondrial Function and Survival after Hepatic Ischemia-Reperfusion.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  103. SANTI V , Buccione D, Di Micoli A, Fatti G, et al
    The changing scenario of hepatocellular carcinoma over the last two decades in Italy.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  104. KAMIMURA H , Yamagiwa S, Tsuchiya A, Takamura M, et al
    Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  105. SINGH V , Dhungana SP, Singh B, Vijayverghia R, et al
    Midodrine In Patients With Cirrhosis And Refractory Or Recurrent Ascites: A Randomized Pilot Study.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  106. TOMIMARU Y , Eguchi H, Nagano H, Wada H, et al
    Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  107. LU X , Guo H, Molter J, Miao H, et al
    Alpha-fetoprotein-thymidine kinase-luciferase knockin mice: a novel model for dual modality longitudinal imaging of tumorigenesis in liver.
    J Hepatol. 2011;55:96-102.
    PubMed     Text format     Related articles    Abstract available



  108. VAN AALTEN SM , Verheij J, Terkivatan T, Dwarkasing RS, et al
    Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
    J Hepatol. 2011;55:120-5.
    PubMed     Text format     Related articles    Abstract available



  109. DUCHARTRE Y , Petit N, Moya C, Lalanne M, et al
    Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
    J Hepatol. 2011;55:162-70.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  110. VIOLI F , Basili S, Raparelli V, Chowdary P, et al
    Patients with Liver Cirrhosis Suffer from Primary Haemostatic Defects? Fact or Fiction?
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  111. BASSENDINE MF , Sheridan DA, Felmlee DJ, Bridge SH, et al
    HCV and the hepatic lipid pathway as a potential treatment target.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  112. ROSMORDUC O , Desbois-Mouthon C
    "Targeting STAT3 in Hepatocellular Carcinoma: Sorafenib again..."
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  113. THABUT D , Rudler M, Lebrec D
    Early TIPS with covered stents in high-risk patients with cirrhosis presenting with variceal bleeding: are we ready to dive into the deep end of the pool?
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  114. BEUERS U , Lindor KD
    A major step towards effective treatment evaluation in primary biliary cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  115. MACHADO MV , Cortez-Pinto H
    No need for a large belly to have NASH.
    J Hepatol. 2011;54:1090-3.
    PubMed     Text format     Related articles   



  116. PIGUET AC , Dufour JF
    PI(3)K/PTEN/AKT pathway.
    J Hepatol. 2011;54:1317-9.
    PubMed     Text format     Related articles   



  117. MCPHAIL MJ
    Improving MELD for use in acute liver failure.
    J Hepatol. 2011;54:1320.
    PubMed     Text format     Related articles   



  118. MISHRA SR , Sharma BC, Kumar A, Sarin SK, et al
    Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial.
    J Hepatol. 2011;54:1161-7.
    PubMed     Text format     Related articles    Abstract available



  119. SAINT-AURET G , Danan JL, Hiron M, Blache C, et al
    Characterization of the transcriptional signature of C/EBPbeta isoforms (LAP/LIP) in Hep3B cells: implication of LIP in pro-survival functions.
    J Hepatol. 2011;54:1185-94.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  120. MARSHALL A , Alexander G
    Vascular invasion leaves its' mark in Hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  121. EL-BADRY AM , Jang JH, Elsherbiny A, Contaldo C, et al
    Chemical Composition of Hepatic Lipids Mediates Reperfusion Injury of the Macrosteatotic Mouse Liver through Thromboxane A(2).
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  122. ALPINI G , Glaser SS, Zhang JP, Francis H, et al
    Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  123. N'KONTCHOU G , Aout M, Laurent A, Nahon P, et al
    Survival after Radiofrequency Ablation and Salvage Transplantation in Patients with Hepatocellular Carcinoma and Child-Pugh A Cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  124. KUDO Y , Tanaka Y, Tateishi K, Yamamoto K, et al
    Altered Composition of Fatty Acids Exacerbates Hepatotumorigenesis during Activation of the Phosphatidylinositol 3-kinase Pathway.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  125. GUI Y , Yeganeh M, Ramanathan S, Leblanc C, et al
    SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  126. CORPECHOT C , Gaouar F, Chretien Y, Johanet C, et al
    Smoking as an Independent Risk Factor of Liver Fibrosis in Primary Biliary Cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  127. NAMUR J , Citron SJ, Sellers MT, Dupuis MH, et al
    Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  128. SHARMA M , Urano F, Jaeschke A
    Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  129. VILLANUEVA A , Hoshida Y
    Depicting the role of TP53 in hepatocellular carcinoma progression.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  130. FAUSTHER M , Dranoff JA
    New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout mice.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  131. GRETEN FR
    TAK1: Another mesh in the NF-kappaB - JNK controlled network causing hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  132. POELSTRA K , Schuppan D
    Targeted therapy of liver fibrosis/cirrhosis and its complications.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  133. FRIEDMAN SL
    Focus.
    J Hepatol. 2011;54:841-3.
    PubMed     Text format     Related articles   



  134. SCHRADER J , Iredale JP
    The inflammatory microenvironment of HCC - the plot becomes complex.
    J Hepatol. 2011;54:853-5.
    PubMed     Text format     Related articles   



  135. LI H , Zhang B, Lu Y, Jorgensen M, et al
    Adipose tissue-derived mesenchymal stem cell-based liver gene delivery.
    J Hepatol. 2011;54:930-8.
    PubMed     Text format     Related articles    Abstract available



  136. QI X , Han G, Bai M, Fan D, et al
    Stage of portal vein thrombosis.
    J Hepatol. 2011;54:1080-2.
    PubMed     Text format     Related articles   



  137. TARGHER G , Chonchol M, Zoppini G, Abaterusso C, et al
    Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?
    J Hepatol. 2011;54:1020-9.
    PubMed     Text format     Related articles    Abstract available



  138. LLACUNA L , Fernandez A, Montfort CV, Matias N, et al
    Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
    J Hepatol. 2011;54:1002-10.
    PubMed     Text format     Related articles    Abstract available



  139. TYBL E , Shi FD, Kessler SM, Tierling S, et al
    Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype.
    J Hepatol. 2011;54:994-1001.
    PubMed     Text format     Related articles    Abstract available



  140. DASARATHY S , McCullough AJ, Muc S, Schneyer A, et al
    Sarcopenia associated with portosystemic shunting is reversed by follistatin.
    J Hepatol. 2011;54:915-21.
    PubMed     Text format     Related articles    Abstract available



  141. HAEDRICH M , Dufour JF
    UDCA for NASH: end of the story?
    J Hepatol. 2011;54:856-8.
    PubMed     Text format     Related articles   



  142. TALENS S , Hoekstra J, Dirkx SP, Darwish Murad S, et al
    Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome.
    J Hepatol. 2011;54:908-14.
    PubMed     Text format     Related articles    Abstract available



  143. BUREAU C , Metivier S, D'Amico M, Peron JM, et al
    Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS.
    J Hepatol. 2011;54:901-7.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  144. SHOUVAL D
    Further evidence for the potential role of mTOR inhibitors in the prevention of post-transplantation hepatic fibrosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  145. SCHATTENBERG JM , Zimmermann T, Worns M, Sprinzl MF, et al
    Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  146. GILLMORE R , Stuart S, Kirkwood A, Hameeduddin A, et al
    EASL And mRecist Responses Are Independent Prognostic Factors For Survival In Hepatocellular Cancer Patients Treated With Transarterial Embolisation.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  147. MAHADY SE , Webster AC, Walker S, Sanyal A, et al
    "The role of thiazolidinediones in non-alcoholic steatohepatitis- a systematic review and meta analysis"
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  148. TILLMANN HL , Patel K, Muir AJ, Guy CD, et al
    Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  149. GABELE E , Dostert K, Hofmann C, Wiest R, et al
    DSS Induced Colitis Increases Portal LPS Levels and Enhances Hepatic Inflammation and Fibrogenesis in Experimental NASH.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  150. GLENN TK , Honar H, Liu H, Ter Keurs HE, et al
    Role of Cardiac Myofilament Proteins Titin and Collagen in the Pathogenesis of Diastolic Dysfunction in Cirrhotic Rats.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  151. MINGUEZ B , Hoshida Y, Villanueva A, Toffanin S, et al
    Gene-expression signature of vascular invasion in hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  152. SALERNO F , Cazzaniga M, Merli M, Spinzi G, et al
    Diagnosis, Treatment and Survival of Patients with Hepatorenal Syndrome: A Survey on Daily Medical Practice.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  153. CORPECHOT C , Chazouilleres O, Poupon R
    Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  154. WICKLINE ED , Awuah PK, Behari J, Ross M, et al
    Hepatocyte gamma-catenin compensates for conditionally deleted beta-catenin at adherens junctions.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  155. TSOCHATZIS EA , Gurusamy KS, Ntaoula S, Cholongitas E, et al
    Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy.
    J Hepatol. 2011;54:650-9.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  156. SENZOLO M , Patch D, Burra P, Burroughs AK, et al
    Tips for Portal Vein Thrombosis (PVT) in Cirrhosis: Not Only Unblocking a Pipe.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  157. ANGELI P
    beta-blockers and refractory ascites in cirrhosis: the message of a team of true scientists.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  158. MOOKERJEE RP , Lackner C, Stauber R, Stadlbauer V, et al
    The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  159. SUN H , Chen L, Zhou W, Hu L, et al
    The protective role of hydrogen-rich saline in experimental liver injury in mice.
    J Hepatol. 2011;54:471-80.
    PubMed     Text format     Related articles    Abstract available



  160. MUTEL E , Abdul-Wahed A, Ramamonjisoa N, Stefanutti A, et al
    Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas.
    J Hepatol. 2011;54:529-37.
    PubMed     Text format     Related articles    Abstract available



  161. POYNARD T
    First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy.
    J Hepatol. 2011;54:586-7.
    PubMed     Text format     Related articles   



  162. THACHIL J
    Anemia--the overlooked factor in bleeding related to liver disease.
    J Hepatol. 2011;54:593-4.
    PubMed     Text format     Related articles   



  163. COTTE L , Benet T, Billioud C, Miailhes P, et al
    The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.
    J Hepatol. 2011;54:489-96.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  164. EZQUER M , Ezquer F, Ricca M, Allers C, et al
    Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  165. NISCHALKE HD , Berger C, Aldenhoff K, Thyssen L, et al
    Toll-like receptor (TLR) 2 promotor and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  166. ROBIC MA , Procopet B, Metivier S, Peron JM, et al
    Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  167. BRUYAND M , Dabis F, Vandenhende MA, Lazaro E, et al
    HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  168. RAJ A , McCall J, Gane E
    "Validation of the "Metroticket" predictor in a cohort of patients transplanted for predominantly HBV-related Hepatocellular Carcinoma"
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  169. LEONI VP , Ledda-Columbano GM, Pibiri M, Saliba C, et al
    Expression of C-Jun is Not Mandatory for Mouse Hepatocyte Proliferation Induced by Two Nuclear Receptor Ligands: Tcpobop and T3.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  170. BRAREN R , Altomonte J, Settles M, Neff F, et al
    Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  171. KAMARI Y , Shaish A, Vax E, Shemesh S, et al
    Lack of Interleukin-1alpha or Interleukin-1beta Inhibits Transformation of Steatosis to Steatohepatitis and Liver Fibrosis in Hypercholesterolemic Mice.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  172. HERNAEZ R , Yeung E, Clark JM, Kowdley KV, et al
    Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  173. SERSTE T , Francoz C, Durand F, Rautou PE, et al
    Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  174. KIM MY , Cho MY, Baik SK, Park HJ, et al
    Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  175. TAI WT , Cheng AL, Shiau CW, Huang HP, et al
    Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  176. XI B , Zeng T
    Null genotypes of GSTM1 and GSTT1 both associated with increased hepatocellular carcinoma risk in Asians: new evidence.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  177. RYAN JD , Crowe J
    Hepatocyte iron accumulation: A new string to ribavirin's antiviral bow?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  178. GINES P
    Pharmacological management of hepatorenal syndrome. Lessons from non-responders.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  179. FILLEBEEN C , Pantopoulos K
    Reply to: Hepatocyte iron accumulation: A new string to ribavirin's antiviral bow?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  180. BERGE M , Allanic D, Bonnin P, Montrion CD, et al
    Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  181. HSU CY , Shen YC, Yu CW, Hsu C, et al
    Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  182. LUCIANI A , Baranes L, Decaens T, Pigneur F, et al
    Non Invasive Diagnostic Imaging of Hepato Cellular Carcinoma: targeting cellular characterization?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  183. KITAMURA K , Hatano E, Higashi T, Narita M, et al
    Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  184. CHEN X , Lingala S, Khoobyari S, Nolta J, et al
    Epithelial Mesenchymal Transition and Hedgehog Signaling Activation are Associated with Chemoresistance and Invasion of Hepatoma Subpopulations.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  185. SALVATORE P , Filippo M, Silvano F, Marta C, et al
    Continuous Recurrence of Type 1 Hepatorenal Syndrome and Long-Term Treatment with Terlipressin and Albumin: a New Exception to Meld Score in the Allocation System to Liver Transplantation?
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  186. TREPO E , Gustot T, Degre D, Lemmers A, et al
    Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  187. MERANI S , Majno P, Kneteman NM, Berney T, et al
    The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  188. COANT N , Simon-Rudler M, Gustot T, Fasseu M, et al
    Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  189. MENG Z , Liu N, Fu X, Wang X, et al
    Insufficient bile acid signaling impairs liver repair in CYP27(-/-) mice.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  190. FERNANDEZ-RUIZ V , Kawa M, Berasain C, Iniguez M, et al
    Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  191. DULTZ G , Kronenberger B, Azizi A, Mihm U, et al
    Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  192. BIOULAC-SAGE P , Balabaud C, Zucman-Rossi J
    Will the pathomolecular classification of hepatocellular adenoma improve their clinical management?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  193. TRINCHET JC
    Surveillance for hepatocellular carcinoma in cirrhotic patients: from official recommendations to the real life.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  194. BRUCK J , Gorg B, Bidmon HJ, Zemtsova I, et al
    Locomotor impairment and cerebrocortical oxidative stress in portal vein ligated rats in vivo.
    J Hepatol. 2011;54:251-7.
    PubMed     Text format     Related articles   



  195. CALVISI DF , Ladu S, Conner EA, Seo D, et al
    Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer.
    J Hepatol. 2011;54:311-9.
    PubMed     Text format     Related articles   



  196. JAYAKUMAR AR , Valdes V, Norenberg MD
    The Na-K-Cl cotransporter in the brain edema of acute liver failure.
    J Hepatol. 2011;54:272-8.
    PubMed     Text format     Related articles   



    January 2011
  197. BERZSENYI MD , Woollard DJ, McLean CA, Preiss S, et al
    Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  198. PALMERI ML , Wang MH, Rouze NC, Abdelmalek MF, et al
    Noninvasive Evaluation of Hepatic Fibrosis using Acoustic Radiation Force-Based Shear Stiffness in Patients with Nonalcoholic Fatty Liver Disease.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  199. XU J , Lai KK, Verlinsky A, Lugea A, et al
    Synergistic Steatohepatitis by Moderate Obesity and Alcohol in Mice Despite Increased Adiponectin and p-AMPK.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  200. LENCI I , Tisone G, Di Paolo D, Marcuccilli F, et al
    Safety of Complete and Sustained Prophylaxis Withdrawal in Patients Liver Transplanted for HBV-Related Cirrhosis at Low Risk of HBV Recurrence.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  201. LI ZY , Xi Y, Zhu WN, Zeng C, et al
    Positive Regulation of Hepatic miR-122 Expression by HNF4alpha
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  202. FIEL MI , Deniz K, Elmali F, Schiano TD, et al
    Increasing Hepatic Arteriole Wall Thickness and Decreased Luminal Diameter Occur With Increasing Age in Normal Livers.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  203. TRITTO G , Bechlis Z, Stadlbauer V, Davies N, et al
    Evidence of Neutrophil Functional Defect Despite Inflammation in Stable Cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  204. DERDAK Z , Lang CH, Villegas KA, Tong M, et al
    Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease.
    J Hepatol. 2011;54:164-72.
    PubMed     Text format     Related articles    Abstract available



  205. SIMONEN P , Kotronen A, Hallikainen M, Sevastianova K, et al
    Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity.
    J Hepatol. 2011;54:153-9.
    PubMed     Text format     Related articles    Abstract available



  206. RUFFILLO G , Fassio E, Alvarez E, Landeira G, et al
    Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease.
    J Hepatol. 2011;54:160-3.
    PubMed     Text format     Related articles    Abstract available



  207. RAUTOU PE , Douarin L, Denninger MH, Escolano S, et al
    Bleeding in patients with Budd-Chiari syndrome.
    J Hepatol. 2011;54:56-63.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  208. TAKANO T , Tsukiyama-Kohara K, Hayashi M, Hirata Y, et al
    Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  209. MA X , Xu L, Wang S, Cui B, et al
    Deletion of Steroid receptor coactivator-3 gene ameliorates hepatic steatosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  210. LO L , McLennan SV, F Williams P, Bonner J, et al
    Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  211. MEYER C , Godoy P, Bachmann A, Liu Y, et al
    Distinct role of endocytosis for Smad and non Smad TGF-beta signaling regulation in hepatocytes.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  212. MANCO M , Alisi A, Real JM, Equitani F, et al
    Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  213. WANG J , Ma Y, Jiang H, Zhu H, et al
    Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  214. WANG X , Ikejima K, Kon K, Arai K, et al
    Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  215. BERZIGOTTI A , Nicolau C, Bellot P, Abraldes JG, et al
    Evaluation of Regional Hepatic Perfusion (RHP) by Contrast-ENHANCED Ultrasound in Patients with Cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  216. BOYER TD , Sanyal AJ, Garcia-Tsao G, Blei A, et al
    Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  217. GUEVARA M , Baccaro ME, Gomez-Anson B, Frisoni G, et al
    Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  218. CHEN L , Charrier AL, Leask A, French SW, et al
    Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  219. VAN DEN BROEK MA , Bloemen JG, Dello SA, van de Poll MC, et al
    Randomized controlled trial analyzing the effect of 15 or 30 minutes intermittent Pringle manoeuvre on hepatocellular damage during liver surgery.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  220. CAJA L , Sancho P, Bertran E, Fabregat I, et al
    Dissecting the effect of targeting the epidermal growth factor receptor on TGF-beta-induced-apoptosis in human hepatocellular carcinoma cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  221. ROAYAIE S , Bassi D, Tarchi P, Labow D, et al
    Second hepatic resection for recurrent hepatocellular cancer: a western experience.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  222. MASON AL
    The evidence supports a viral aetiology for primary biliary cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  223. AIRES CC , Cruchten AV, Ijlst L, de Almeida IT, et al
    New insights on the mechanisms of valproate-induced hyperammonemia: Inhibition of hepatic N-acetylglutamate synthase activity by valproyl-Coa.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  224. SELMI C
    The evidence does not support a viral etiology for primary biliary cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  225. ASSY N
    Sub clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: A randomized controlled study Journal of Hepatology JHEPAT-D-10-00373R3.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  226. PRADELLA P , Bonetto S, Turchetto S, Uxa L, et al
    Platelet production and destruction in liver cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  227. TAMIMI TI , Elgouhari HM, Alkhouri N, Yerian LM, et al
    An Apoptosis Panel for Nonalcoholic Steatohepatitis Diagnosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  228. XU CF , Reck BH, Goodman VL, Xue Z, et al
    Association of the Hemochromatosis Gene with Pazopanib-Induced Transaminase Elevation in Renal Cell Carcinoma.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  229. MARDINI H , Smith FE, Record CO, Blamire AM, et al
    Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  230. LARREY D , Faure S
    Herbal medicine hepatotoxicity: A new step with development of specific biomarkers.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  231. FRAU M , Ladu S, Calvisi DF, Simile MM, et al
    Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  232. CORDOBA J
    New Assessment of Hepatic Encephalopathy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  233. PRAVEEN S , Shweta S, Chander SB
    Propofol in patients with cirrhosis and minimal hepatic encephalopathy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  234. MARIJON H , Dokmak S, Paradis V, Zappa M, et al
    Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  235. SHAWCROSS DL , Sharifi Y, Canavan JB, Yeoman AD, et al
    Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  236. INVERNIZZI P
    Drug-induced liver injury: is it time for genetics to change our clinical practice?
    J Hepatol. 2010;53:993-4.
    PubMed     Text format     Related articles   



  237. LALIOTI V , Sandoval I, Cassio D, Duclos-Vallee JC, et al
    Molecular pathology of Wilson's disease: a brief.
    J Hepatol. 2010;53:1151-3.
    PubMed     Text format     Related articles   



  238. NIJKAMP MW , Hoogwater FJ, Steller EJ, Westendorp BF, et al
    CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation.
    J Hepatol. 2010;53:1069-77.
    PubMed     Text format     Related articles    Abstract available



  239. ZHOU M , Xu A, Lam KS, Tam PK, et al
    Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin.
    J Hepatol. 2010;53:1108-16.
    PubMed     Text format     Related articles    Abstract available



  240. TEUFEL A , Maass T, Strand S, Kanzler S, et al
    Liver-specific Ldb1 deletion results in enhanced liver cancer development.
    J Hepatol. 2010;53:1078-84.
    PubMed     Text format     Related articles    Abstract available



  241. LAHARIE D , Seneschal J, Schaeverbeke T, Doutre MS, et al
    Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study.
    J Hepatol. 2010;53:1035-40.
    PubMed     Text format     Related articles    Abstract available



  242. BJERRING PN , Hauerberg J, Jorgensen L, Frederiksen HJ, et al
    Brain hypoxanthine concentration correlates to lactate/pyruvate ratio but not intracranial pressure in patients with acute liver failure.
    J Hepatol. 2010;53:1054-8.
    PubMed     Text format     Related articles    Abstract available



  243. DONALDSON PT , Daly AK, Henderson J, Graham J, et al
    Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.
    J Hepatol. 2010;53:1049-53.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  244. TORRE C , Benhamouche S, Mitchell C, Godard C, et al
    The Transforming Growth Factor-alpha and cyclin D1 genes are direct targets of beta-catenin signaling in hepatocyte proliferation.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  245. DUBUQUOY C , Robichon C, Lasnier F, Langlois C, et al
    Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  246. GONZALEZ R , Cruz A, Ferrin G, Lopez-Cillero P, et al
    Nitric oxide mimicks transcriptional and post-translational regulation during alpha-tocopherol cytoprotection against glycochenodeoxycholate-induced cell death in hepatocytes.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  247. IBRAHIM SH , Akazawa Y, Cazanave SC, Bronk SF, et al
    Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  248. FERRY N
    Adipose-tissue derived hepatic stem cells for gene therapy: fat goes to liver's rescue?
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  249. GEHRING AJ , Xue SA, Ho ZZ, Teoh D, et al
    Engineering Virus-specific T cells that Target HBV Infected Hepatocytes and Hepatocellular Carcinoma Cell Lines.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  250. TREPO E , Potthoff A, Pradat P, Bakshi R, et al
    Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  251. PIANA G , Trinquart L, Meskine N, Barrau V, et al
    New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  252. PERRET C
    Methylation profile as a new tool for classification of hepatocellular carcinoma.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  253. BERNARDI M , Gitto S, Biselli M
    The meld score in patients awaiting liver transplant: strengths and weaknesses (revised version 1).
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  254. KUANG DM , Zhao Q, Wu Y, Peng C, et al
    Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  255. MCCORMACK L , Dutkowski P, El-Badry AM, Clavien PA, et al
    "Liver transplantation using fatty livers: always feasible?"
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  256. LIN HC , Yang YY, Tsai TH, Huang CM, et al
    The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  257. ZEISEL MB , Fofana I, Fafi-Kremer S, Baumert TF, et al
    Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  258. FRACANZANI AL , Valenti L, Bugianesi E, Vanni E, et al
    Risk of non alcoholic steatohepatitis and fibrosis in patients with non alcoholic fatty liver disease and low visceral adiposity.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  259. RIPOLL C , Yotti R, Bermejo J, Banares R, et al
    The heart in liver transplantation.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  260. VOICAN CS , Perlemuter G
    Insulin resistance and oxidative stress: Two therapeutic targets in non-alcoholic steatohepatitis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  261. WEN H , Yoo SS, Lee DH, Park S, et al
    A new NMR metabolomics-based diagnosis for hepatobiliary tract cancer.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  262. MAURY E , Vergniol J, de Ledinghen V, Rigalleau V, et al
    Skin Autofluorescence is high in patients with cirrhosis - further arguing for the implication of Advanced Glycation End Products.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  263. WAIDMANN O , Hofmann WP, Zeuzem S, Trojan J, et al
    mTOR inhibitors and sorafenib for recurrent heptocellular carcinoma after orthotopic liver transplantation.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  264. BREOUS E , Thimme R
    Potential of immunotherapy for hepatocellular carcinoma.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  265. ISHIKAWA S , Ikejima K, Yamagata H, Aoyama T, et al
    CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  266. GRASSELLI E , Voci A, Canesi L, De Matteis R, et al
    Direct effects of iodothyronines on excess fat storage in rat hepatocytes.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  267. MORRIS-STIFF G , Feldstein AE
    Fibroblast growth factor 21 as a biomarker for NAFLD: integrating pathobiology into clinical practice.
    J Hepatol. 2010;53:795-6.
    PubMed     Text format     Related articles   



  268. STICKEL F , Hampe J
    Dissecting the evolutionary genetics of iron overload in non-alcoholic fatty liver disease.
    J Hepatol. 2010;53:793-4.
    PubMed     Text format     Related articles   



  269. TAN T , Chang L, Woodward A, McWhinney B, et al
    Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease.
    J Hepatol. 2010;53:841-8.
    PubMed     Text format     Related articles    Abstract available



  270. VALENTI L , Canavesi E, Galmozzi E, Dongiovanni P, et al
    Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease.
    J Hepatol. 2010;53:927-33.
    PubMed     Text format     Related articles    Abstract available



  271. HOARE M , Das T, Alexander G
    Ageing, telomeres, senescence, and liver injury.
    J Hepatol. 2010;53:950-61.
    PubMed     Text format     Related articles    Abstract available



  272. SHOUVAL D
    The impact of fatigue and treatment with ursodeoxycholic acid on the prognosis of primary biliary cirrhosis: an extended 9 year follow-up.
    J Hepatol. 2010;53:789.
    PubMed     Text format     Related articles   



    October 2010
  273. MARTIN J , Dufour JF
    Abnormal nitrosothiols metabolism in hepatocellular carcinoma.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  274. LI C , Zheng S, You H, Liu X, et al
    Sphingosine 1-Phosphate (S1P)/S1P Receptors Is Involved in Human Liver Fibrosis by Action on Hepatic Myofibroblasts Motility.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  275. GAO P , Chak-Lui Wong C, Kwok-Kwan Tung E, Man-Fong Lee J, et al
    Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  276. NECHEMIA-ARBELY Y , Shriki A, Denz U, Drucker C, et al
    Early Hepatocyte DNA Synthetic Response Posthepatectomy is Modulated by IL-6 Trans-Signaling and PI3K/AKT Activation.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  277. PARK S , Choi Y, Um SJ, Yoon SK, et al
    Oleuropein Attenuates Hepatic Steatosis Induced by High-Fat Diet in Mice.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  278. RATZIU V , Ledinghen VD, Oberti F, Mathurin P, et al
    A randomized controlled trial of high-dose ursodesoxycholic acid For nonalcoholic steatohepatitis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  279. NOVO E , Busletta C, di Bonzo LV, Povero D, et al
    Intracellular Reactive Oxygen Species Are Required For Directional Migration Of Resident And Bone Marrow-Derived Hepatic Pro-Fibrogenic Cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  280. UM TH , Kim H, Oh BK, Kim MS, et al
    Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  281. IACOBINI C , Menini S, Ricci C, Fantauzzi CB, et al
    Galectin-3 ablation protects mice from diet-induced nonalcoholic steatohepatitis.Major scavenging role of galectin-3 in liver.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  282. CAZALS-HATEM D , Hillaire S, Rudler M, Plessier A, et al
    Obliterative portal venopathy: Portal hypertension is not always present at diagnosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  283. SHLOMO SB , Zvibel I, Shnell M, Shlomai A, et al
    Glucagon-Like Peptide-1 reduces hepatic lipogenesis via activation of AMP-activated Protein Kinase.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  284. OHARA E , Hiraga N, Imamura M, Iwao E, et al
    Elimination of Hepatitis C Virus by Short Term NS3-4A and NS5B Inhibitor Combination Therapy in Human Hepatocyte Chimeric Mice.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  285. RIAZ A , Memon K, Miller FH, Nikolaidis P, et al
    Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: Radiologic-pathologic correlation.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  286. STIEGER B
    Regulation of the expression of the hepatocellular sulfate-oxalate exchanger SAT-1 (SLC26A1) by glyoxylate: A metabolic link between liver and kidney?
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  287. MONTAGNESE S , Middleton B, Mani AR, Skene DJ, et al
    Changes in the 24-h plasma cortisol rhythm in patients with cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  288. GALBOIS A , Thabut D
    Adrenal insufficiency: Diagnosis in patients with liver cirrhosis is difficult.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  289. FORETZ M , Viollet B
    Regulation of hepatic metabolism by AMPK.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  290. LI YW , Qiu SJ, Fan J, Zhou J, et al
    Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  291. DE GRAAF W , Hausler S, Heger M, van Ginhoven TM, et al
    Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  292. NAGAYA T , Tanaka N, Suzuki T, Sano K, et al
    Down-regulation of SREBP-1c is associated with the development of burned-out NASH.
    J Hepatol. 2010;53:724-31.
    PubMed     Text format     Related articles    Abstract available



  293. SHOUVAL D
    Focus.
    J Hepatol. 2010;53:591-2.
    PubMed     Text format     Related articles   



  294. BECHMANN LP , Jochum C, Kocabayoglu P, Sowa JP, et al
    Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury.
    J Hepatol. 2010;53:639-47.
    PubMed     Text format     Related articles    Abstract available



  295. TARGHER G , Bertolini L, Padovani R, Rodella S, et al
    Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.
    J Hepatol. 2010;53:713-8.
    PubMed     Text format     Related articles    Abstract available



  296. VAN DER BIJ GJ , Bogels M, Otten MA, Oosterling SJ, et al
    Experimentally induced liver metastases from colorectal cancer can be prevented by mononuclear phagocyte-mediated monoclonal antibody therapy.
    J Hepatol. 2010;53:677-85.
    PubMed     Text format     Related articles    Abstract available



  297. SAMUEL D , Ichai P
    Prognosis indicator in acute liver failure: Is there a place for cell death markers?
    J Hepatol. 2010;53:593-5.
    PubMed     Text format     Related articles   



  298. ROLDAN-VALADEZ E , Favila R, Martinez-Lopez M, Uribe M, et al
    In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry.
    J Hepatol. 2010;53:732-7.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  299. PARK SY , Tak WY, Jung MK, Jeon SW, et al
    Symptomatic-enlarging hepatic hemangiomas are effectively treated by percutaneous ultrasonography-guided radiofrequency ablation.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  300. JANG JY , Shao RX, Lin W, Weinberg E, et al
    HIV infection increases HCV-induced hepatocyte apoptosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  301. MAGNE L , Blanc E, Legrand B, Lucas D, et al
    ATF4 and the integrated stress response are induced by ethanol and cytochrome P450 2E1 in human hepatocytes.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  302. PATHIL A , Warth A, Chamulitrat W, Stremmel W, et al
    The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFalpha-induced liver injury.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  303. LENCIONI R
    Evolving strategies in the diagnosis of hepatocellular carcinoma.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  304. GARCIA-CALDERO H , Rodriguez-Vilarrupla A, Gracia-Sancho J, Divi M, et al
    Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  305. LAMBERT MP , Paliwal A, Vaissiere T, Chemin I, et al
    Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  306. NOELS JE , van Aalten SM, van der Windt DJ, Kok NF, et al
    Management of hepatocellular adenoma during pregnancy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  307. ZEIN CO , Unalp A, Colvin R, Liu YC, et al
    Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  308. KHALILI K , Kim TK, Jang HJ, Haider MA, et al
    Optimization of imaging diagnosis of 1-2cm hepatocellular carcinoma: An analysis of diagnostic performance and resource utilization.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  309. LIN G , Wang JY, Li N, Li M, et al
    Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  310. WENG SY , Yang CY, Li CC, Sun TP, et al
    Synergism between p53 and Mcl-1 in protecting from hepatic injury, fibrosis and cancer.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  311. DOIGNON I , Julien B, Serriere-Lanneau V, Garcin I, et al
    Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  312. GUACHALLA LM , Rudolph KL
    The GAPs between hepatocellular carcinoma and RAS.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  313. SHIMADA H , Staten NR, Rajagopalan LE
    TGF-beta1 mediated activation of Rho kinase induces TGF-beta2 and endothelin-1 expression in human hepatic stellate cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  314. FABRIS C , Falleti E, Cussigh A, Bitetto D, et al
    IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  315. MYERS RP , Shaheen AA, Aspinall AI, Quinn RR, et al
    Gender, renal function, and outcomes on the liver transplant waiting list: Assessment of revised MELD including estimated glomerular filtration rate.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  316. DI PASCOLI M , Zampieri F, Quarta S, Sacerdoti D, et al
    Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  317. DURAND F
    The quest for equity in liver transplantation: Another lesson learned from women.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  318. TAK E , Lee S, Lee J, Rashid MA, et al
    Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  319. NAMBOTIN SB , Lefrancois L, Sainsily X, Berthillon P, et al
    Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  320. FEDE G , Spadaro L, Tomaselli T, Privitera G, et al
    Assessment of adrenocortical reserve in stable patients with cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  321. HAMMOND JS , Gilbert TW, Howard D, Zaitoun A, et al
    Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liver.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  322. JALAN R , Olde Damink SW, Ter Steege JC, Redhead DN, et al
    Acute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patients.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  323. HUANG JF , Yu ML, Huang CF, Chiu CF, et al
    The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - A multicenter prospective trial.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  324. COLECCHIA A , Scaioli E, Montrone L, Vestito A, et al
    Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  325. XIANG WQ , Feng WF, Ke W, Sun Z, et al
    Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  326. SANCHO-BRU P , Roelandt P, Narain N, Pauwelyn K, et al
    Directed differentiation of murine-induced pluripotent stem cells to functional hepatocyte-like cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  327. MENDLER MH , Agarwal A, Trimzi M, Madrigal E, et al
    A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method.
    J Hepatol. 2010;53:477-83.
    PubMed     Text format     Related articles    Abstract available



  328. TRIPODI A , Primignani M, Chantarangkul V, Mannucci PM, et al
    Pro-coagulant imbalance in patients with chronic liver disease.
    J Hepatol. 2010;53:586-7.
    PubMed     Text format     Related articles   



  329. CHEN YW , Liu BW, Zhang YJ, Chen YW, et al
    Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver.
    J Hepatol. 2010;53:528-36.
    PubMed     Text format     Related articles    Abstract available



  330. MARQUARDT JU , Factor VM, Thorgeirsson SS
    Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.
    J Hepatol. 2010;53:568-77.
    PubMed     Text format     Related articles    Abstract available



  331. MCPHAIL MJ , Wendon JA, Bernal W
    Meta-analysis of performance of Kings's College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure.
    J Hepatol. 2010;53:492-9.
    PubMed     Text format     Related articles    Abstract available



  332. ELSHARKAWY AM , Oakley F, Lin F, Packham G, et al
    The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes.
    J Hepatol. 2010;53:519-27.
    PubMed     Text format     Related articles    Abstract available



  333. VIEBAHN CS , Benseler V, Holz LE, Elsegood CL, et al
    Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury.
    J Hepatol. 2010;53:500-7.
    PubMed     Text format     Related articles    Abstract available



  334. MEDICI V , Peerson JM, Stabler SP, French SW, et al
    Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease.
    J Hepatol. 2010;53:551-7.
    PubMed     Text format     Related articles    Abstract available



  335. BORDIGNON M , Viel G, Peserico A, Alaibac M, et al
    Non-alcoholic fatty liver disease, alcohol intake and psoriasis.
    J Hepatol. 2010;53:587.
    PubMed     Text format     Related articles   



    August 2010
  336. SIEGHART W , Wang X, Schmid K, Pinter M, et al
    Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  337. GARCIA-MONZON C , Lo Iacono O, Mayoral R, Gonzalez-Rodriguez A, et al
    Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  338. HAN G , Qi X, He C, Yin Z, et al
    Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  339. LIU Z , Rossen EV, Timmermans JP, Geerts A, et al
    Distinct roles for non-muscle myosin II isoforms in mouse hepatic stellate cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  340. CANY J , Barteau B, Tran L, Gauttier V, et al
    AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  341. PARK JR , Kim RJ, Lee YK, Kim SR, et al
    Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  342. KHAMAYSI I , William N, Olga A, Alex I, et al
    Sub-clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: A randomized controlled study.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  343. TOURNOUX-FACON C , Paoletti X, Barbare JC, Bouche O, et al
    Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  344. SALAMONE F , Bugianesi E
    Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  345. SOLA E , Gines P
    Renal and circulatory dysfunction in cirrhosis: Current management and future perspectives.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  346. THABUT D , D'Amico G, Tan P, De Franchis R, et al
    Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: Analysis of the F7 liver-1288 study population.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  347. MCDONALD C , Newton J, Lai HM, Baker SN, et al
    Central nervous system dysfunction in primary biliary cirrhosis and its relationship to symptoms.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  348. CHEN Y , Johansson E, Yang Y, Miller ML, et al
    Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  349. FINKENSTEDT A , Wolf E, Hofner E, Gasser BI, et al
    Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  350. OLLEROS ML , Vesin D, Fotio AL, Santiago-Raber ML, et al
    Soluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  351. FERNANDEZ-VARO G , Melgar-Lesmes P, Casals G, Pauta M, et al
    Inactivation of extrahepatic vascular Akt improves systemic hemodynamics and sodium excretion in cirrhotic rats.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  352. JONES DE , Al-Rifai A, Frith J, Patanwala I, et al
    The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: Results of a 9year follow-up.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  353. TANDON P , Abraldes JG, Berzigotti A, Garcia-Pagan JC, et al
    Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis.
    J Hepatol. 2010;53:273-82.
    PubMed     Text format     Related articles    Abstract available



  354. ROMEO S , Sentinelli F, Cambuli VM, Incani M, et al
    The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
    J Hepatol. 2010;53:335-8.
    PubMed     Text format     Related articles    Abstract available



  355. SALERNO F , Cazzaniga M, Accordino S
    May vaptans contribute to the treatment of refractory ascites?
    J Hepatol. 2010;53:225-7.
    PubMed     Text format     Related articles   



  356. LISMAN T , Caldwell SH, Burroughs AK, Northup PG, et al
    Hemostasis and thrombosis in patients with liver disease: the ups and downs.
    J Hepatol. 2010;53:362-71.
    PubMed     Text format     Related articles    Abstract available



  357. RATZIU V , Bellentani S, Cortez-Pinto H, Day C, et al
    A position statement on NAFLD/NASH based on the EASL 2009 special conference.
    J Hepatol. 2010;53:372-84.
    PubMed     Text format     Related articles   



  358. OBARA N , Fukushima K, Ueno Y, Wakui Y, et al
    Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice.
    J Hepatol. 2010;53:326-34.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  359. SPEICHER T , Foehrenbacher A, Pochic I, Weiland T, et al
    Malignant but not naive hepatocytes of human and rodent origin are killed by TNF after metabolic depletion of ATP by fructose.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  360. MAGGIORE G , Gonzales E, Sciveres M, Redon MJ, et al
    Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  361. BERNARDI M , Santi L
    Renal sodium retention in pre-ascitic cirrhosis: The more we know about the puzzle, the more it becomes intricate.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  362. SANSOE G , Aragno M, Tomasinelli CE, di Bonzo LV, et al
    Calcium-dependent diuretic system in preascitic liver cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  363. THABUT D , Shah V
    Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension?
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  364. HANOUN N , Bureau C, Diab T, Gayet O, et al
    The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  365. GUPTA A , Dhiman RK, Kumari S, Rana S, et al
    Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  366. LI H , Fang Q, Gao F, Fan J, et al
    Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  367. HOHENESTER S , Gates A, Wimmer R, Beuers U, et al
    Phosphatidylinositol-3-kinase p110gamma contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  368. WANG P , Cong M, Liu TH, Yang AT, et al
    Primary isolated hepatic oval cells maintain progenitor cell phenotypes after two-year prolonged cultivation.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  369. ZHANG C , Li H, Wang Y, Liu W, et al
    Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  370. NKONTCHOU G , Bastard JP, Ziol M, Aout M, et al
    Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  371. KOWALIK MA , Perra A, Pibiri M, Cocco MT, et al
    TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  372. SHOUVAL D
    New insight into the mechanism of hepatic involvement in brucellosis.
    J Hepatol. 2010;53:1-2.
    PubMed     Text format     Related articles   



  373. BERNAL W
    Lactate is important in determining prognosis in acute liver failure.
    J Hepatol. 2010;53:209-10.
    PubMed     Text format     Related articles   



  374. WRIGHT G , Soper R, Brooks HF, Stadlbauer V, et al
    Role of aquaporin-4 in the development of brain oedema in liver failure.
    J Hepatol. 2010;53:91-7.
    PubMed     Text format     Related articles    Abstract available



  375. PAWLIKOWSKA L , Strautnieks S, Jankowska I, Czubkowski P, et al
    Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
    J Hepatol. 2010;53:170-8.
    PubMed     Text format     Related articles    Abstract available



  376. SCHMIDT LE , Larsen FS
    Is lactate concentration of major value in determining the prognosis in patients with acute liver failure? Hardly.
    J Hepatol. 2010;53:211-2.
    PubMed     Text format     Related articles   



    June 2010
  377. SOLTYS KA , Soto-Gutierrez A, Nagaya M, Baskin KM, et al
    Barriers to the successful treatment of liver disease by hepatocyte transplantation.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  378. DE FRANCHIS R
    Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  379. XU L , Qian G, Tang L, Su J, et al
    Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  380. TREBICKA J , Hennenberg M, Odenthal M, Shir K, et al
    Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available




  381. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  382. OBEN JA , Mouralidarane A, Samuelsson AM, Matthews PJ, et al
    Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice.
    J Hepatol. 2010;52:913-20.
    PubMed     Text format     Related articles    Abstract available



  383. BURROUGHS AK , Tsochatzis EA, Triantos C
    Primary prevention of variceal haemorrhage: a pharmacological approach.
    J Hepatol. 2010;52:946-8.
    PubMed     Text format     Related articles   



  384. NOBILI V , Cianfarani S, Agostoni C
    Programming, metabolic syndrome, and NAFLD: the challenge of transforming a vicious cycle into a virtuous cycle.
    J Hepatol. 2010;52:788-90.
    PubMed     Text format     Related articles   



  385. RUDOVICH NN , Weickert MO, Machann J, Pfeiffer AF, et al
    Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance?
    J Hepatol. 2010;52:952-3.
    PubMed     Text format     Related articles   



  386. ROTIMI O
    Re: soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
    J Hepatol. 2010;52:954.
    PubMed     Text format     Related articles   



  387. LAINE L
    Primary prophylaxis of esophageal variceal bleeding: an endoscopic approach.
    J Hepatol. 2010;52:944-5.
    PubMed     Text format     Related articles   



    May 2010
  388. MASTRANGELO G , Martines D, Fedeli U
    Vinyl chloride and the liver: misrepresentation of epidemiological evidence.
    J Hepatol. 2010;52:776-7.
    PubMed     Text format     Related articles   



  389. GONZALEZ SA , Trotter JF
    Renal function and MELD: being direct is better.
    J Hepatol. 2010;52:622-3.
    PubMed     Text format     Related articles   



  390. BERASAIN C
    New therapeutic targets in HCC: reptin ATPase and HCC senescence.
    J Hepatol. 2010;52:633-4.
    PubMed     Text format     Related articles   



    April 2010
  391. WANG Y , Lu Y, Toh ST, Sung WK, et al
    Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  392. HOV JR , Lleo A, Selmi C, Woldseth B, et al
    Genetic associations in Italian primary sclerosing cholangitis: Heterogeneity across Europe defines a critical role for HLA-C.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  393. GAILHOUSTE L , Le Grand Y, Odin C, Guyader D, et al
    Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis.
    J Hepatol. 2010;52:398-406.
    PubMed     Text format     Related articles    Abstract available



  394. BEDOSSA P
    Harmony in liver fibrosis...
    J Hepatol. 2010;52:313-4.
    PubMed     Text format     Related articles   



  395. KARPEN SJ , Trauner M
    The new therapeutic frontier--nuclear receptors and the liver.
    J Hepatol. 2010;52:455-62.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  396. PATSENKER E , Wilkens L, Banz V, Osterreicher CH, et al
    The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  397. DOLLE L , Best J, Mei J, Al Battah F, et al
    The quest for liver progenitor cells: a practical point of view.
    J Hepatol. 2010;52:117-29.
    PubMed     Text format     Related articles    Abstract available



  398. LOHSE AW , Weiler-Normann C, Tiegs G
    Immune-mediated liver injury.
    J Hepatol. 2010;52:136-44.
    PubMed     Text format     Related articles   



  399. FRITH J , Day CP, Robinson L, Elliott C, et al
    Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease.
    J Hepatol. 2010;52:112-6.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: